Cudkowicz G, Bennett M
J Exp Med. 1971 Dec 1;134(6):1513-28. doi: 10.1084/jem.134.6.1513.
F(1) hybrid mice are capable of rejecting inbred parental strain bone marrow grafts after a single lethal exposure to X-rays. The incompatibility is genetically controlled by the Hybrid-histocompatibility-1 (Hh-1) locus in or near the D end of the Histocompatibility-2 (H-2) region. The onset of parental graft rejection begins 9-12 hr after transplantation and is completed by 24 hr. Maturation of hybrid resistance does not occur until the 22nd day of life. In adults, the resistance to parental marrow grafts can be temporarily abrogated or weakened by administration of cyclophosphamide or dead cultures of Corynebacterium parvum, acute supralethal exposures to radiation, or by split-dose irradiation with 6-37-day intervals. Parental marrow grafts elicit a transplantation reaction in irradiated F(1) mice which is indistinguishable from that elicited in irradiated allogeneic (H-2-incompatible) hosts. Because of this immunogenetic similarity, the following question is raised: are the same or different alloantigens responsible for rejection of parental and allogeneic marrow grafts? In the first case, Hh-1 alleles would be recessive determinants of tissue-specific transplantation antigens, whereas in the second case they would be the determinants of parental- and tissue-specific antigens subject to genetic suppression in Hh-1 heterozygotes. Although the available evidence is not conclusive in excluding one of the two possibilities, it favors the concept that allograft reactivity to hemopoietic cells is elicited by recessive tissue-specific antigens.
F(1)杂种小鼠在单次致死剂量的X射线照射后,能够排斥近交系亲本品系的骨髓移植。这种不相容性由组织相容性-2(H-2)区域D端或其附近的杂种组织相容性-1(Hh-1)位点进行遗传控制。亲代移植排斥反应在移植后9 - 12小时开始,并在24小时内完成。杂种抗性直到出生后第22天才成熟。在成年小鼠中,对亲代骨髓移植的抗性可通过给予环磷酰胺或微小棒状杆菌死培养物、急性超致死剂量辐射,或间隔6 - 37天的分次照射而暂时消除或减弱。亲代骨髓移植在受照射的F(1)小鼠中引发的移植反应,与在受照射的同种异体(H-2不相容)宿主中引发的反应无法区分。由于这种免疫遗传学相似性,引发了以下问题:负责排斥亲代和同种异体骨髓移植的是相同还是不同的同种抗原?在第一种情况下,Hh-1等位基因将是组织特异性移植抗原的隐性决定因素,而在第二种情况下,它们将是亲代和组织特异性抗原的决定因素,在Hh-1杂合子中受到遗传抑制。尽管现有证据在排除这两种可能性之一方面并不确凿,但它支持同种异体对造血细胞的反应性是由隐性组织特异性抗原引发的这一概念。